Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 9034324 Anti-BCMA antibodies

Patent 9034324 was granted and assigned to Biogen on May, 2015 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 9 Oct, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 9 Oct, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12109234 Anti-BCMA CAR T cell compositions
0
Edits on 13 Jun, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 13 Jun, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12006369 BCMA chimeric antigen receptors
0
Edits on 1 May, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 1 May, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11970540 Anti-BCMA heavy chain-only antibodies
0
Edits on 24 Apr, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 24 Apr, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11965025 Method of treating solid cancers with bispecific interleukin-anti-TCRß molecules
0
Edits on 22 Feb, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 22 Feb, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11905326 Multispecific heavy chain antibodies binding to CD22 and CD3
0
Edits on 1 Feb, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 1 Feb, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11884720 Antibody constructs for MSLN and CD3
0
Edits on 19 Jan, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 19 Jan, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11873336 Heavy chain antibodies binding to CD22
0
Edits on 3 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 3 Dec, 2023
Edits made to:
Article (+357 characters)
Article

Patent abstract

This invention provides antibodies that recognize the B Cell Maturation Antigen (BCMA) and that bind naïve B cells, plasma cells, and/or memory B cells. The invention further provides methods for depleting naïve B cells, plasma cells, and memory B cells, and for treating B cell-related disorders, including lymphomas and autoimmune diseases.

Edits on 27 Sep, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 27 Sep, 2023
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Susan L. Kalled0
Yen-Ming Hsu0
Edits on 21 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 21 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=090343240
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 20 May, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 09034324 Anti-BCMA antibodies US Patent 9034324 Anti-BCMA antibodies

Infobox
Patent Number
090343240
Patent Number
90343240
Edits on 21 Mar, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 21 Mar, 2023
Infobox
Is a
Patent
Patent
0
Current Assignee
Biogen
Biogen
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
090343240
Date of Patent
May 19, 2015
0
Patent Application Number
132556100
Date Filed
March 10, 2010
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=090343240
Patent Primary Examiner
‌
Laura B Goddard
0
Edits on 8 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 8 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=09034324
Edits on 30 Dec, 2021
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 30 Dec, 2021
Edits made to:
Infobox (+8 properties)
‌

 US Patent 09034324 Anti-BCMA antibodies

Infobox
Is a
Patent
Patent
Current assignee
Biogen
Biogen
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
09034324
Date of patent
May 19, 2015
Patent application number
13255610
Date Filed
March 10, 2010
Patent primary examiner
‌
Laura B Goddard

Find more entities like US Patent 9034324 Anti-BCMA antibodies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.